Trial Outcomes & Findings for Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression (NCT NCT06119854)

NCT ID: NCT06119854

Last Updated: 2025-09-11

Results Overview

Following our theoretical premise that our intervention will impact the uptake of COVID-19 vaccination, the investigators define our primary outcome as self-reported receipt of a COVID vaccine dose in the 4 weeks post-intervention. Risk ratios will be used to estimate and compare the proportion of participants in each arm who achieved the outcome. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances and conduct a mediation analysis to better understand the intervention's mechanisms of action.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1419 participants

Primary outcome timeframe

4 weeks post-intervention

Results posted on

2025-09-11

Participant Flow

Overall, 2,411 CHASING COVID Cohort participants were invited, and 1,419 (59%) were eligible and randomized to the intervention. After completing the 4-week survey, 16 participants were removed from the sample based on data quality protocols, leaving an analytic sample of 1403 participants. Randomization resulted in 469 individuals in CBT-kernels arm, 466 in the Inoculation arm, and 468 in the Standard public health messaging arm

Participant milestones

Participant milestones
Measure
Attitudinal Inoculation Intervention
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation. Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Cognitive Behavioral Therapy-informed Intervention
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging. Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Conventional Public Health Messaging
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging. Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Overall Study
STARTED
472
473
474
Overall Study
COMPLETED
466
469
468
Overall Study
NOT COMPLETED
6
4
6

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Attitudinal Inoculation Intervention
n=466 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation. Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Cognitive Behavioral Therapy-informed Intervention
n=469 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging. Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Conventional Public Health Messaging
n=468 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging. Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Total
n=1403 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
415 Participants
n=5 Participants
416 Participants
n=7 Participants
415 Participants
n=5 Participants
1246 Participants
n=4 Participants
Age, Categorical
>=65 years
51 Participants
n=5 Participants
53 Participants
n=7 Participants
53 Participants
n=5 Participants
157 Participants
n=4 Participants
Sex/Gender, Customized
Gender : Male
183 Participants
n=5 Participants
192 Participants
n=7 Participants
199 Participants
n=5 Participants
574 Participants
n=4 Participants
Sex/Gender, Customized
Gender : Female
263 Participants
n=5 Participants
270 Participants
n=7 Participants
254 Participants
n=5 Participants
787 Participants
n=4 Participants
Sex/Gender, Customized
Gender : Non-binary
20 Participants
n=5 Participants
7 Participants
n=7 Participants
15 Participants
n=5 Participants
42 Participants
n=4 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic
78 Participants
n=5 Participants
84 Participants
n=7 Participants
84 Participants
n=5 Participants
246 Participants
n=4 Participants
Race/Ethnicity, Customized
Race/Ethnicity · White (non-Hispanic)
268 Participants
n=5 Participants
288 Participants
n=7 Participants
286 Participants
n=5 Participants
842 Participants
n=4 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Black (non-Hispanic)
60 Participants
n=5 Participants
49 Participants
n=7 Participants
42 Participants
n=5 Participants
151 Participants
n=4 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Asian/American Indian/Pacific (non-Hispanic)
46 Participants
n=5 Participants
34 Participants
n=7 Participants
40 Participants
n=5 Participants
120 Participants
n=4 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Other/unknown
14 Participants
n=5 Participants
14 Participants
n=7 Participants
16 Participants
n=5 Participants
44 Participants
n=4 Participants
Region of Enrollment
United States · MidWest
72 Participants
n=5 Participants
76 Participants
n=7 Participants
84 Participants
n=5 Participants
232 Participants
n=4 Participants
Region of Enrollment
United States · NorthEast
113 Participants
n=5 Participants
127 Participants
n=7 Participants
134 Participants
n=5 Participants
374 Participants
n=4 Participants
Region of Enrollment
United States · South
167 Participants
n=5 Participants
163 Participants
n=7 Participants
135 Participants
n=5 Participants
465 Participants
n=4 Participants
Region of Enrollment
United States · Other
1 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
3 Participants
n=4 Participants
Region of Enrollment
United States · West
113 Participants
n=5 Participants
102 Participants
n=7 Participants
114 Participants
n=5 Participants
329 Participants
n=4 Participants
Number of COVID-19 vaccine doses as of Dec 2023
3.00 vaccine doses
n=5 Participants
3.00 vaccine doses
n=7 Participants
3.00 vaccine doses
n=5 Participants
3.00 vaccine doses
n=4 Participants

PRIMARY outcome

Timeframe: 4 weeks post-intervention

Population: Overall, 2,411 CHASING COVID Cohort participants were invited, and 1,419 (59%) were eligible and randomized to the intervention. After completing the 4-week survey, 16 participants were removed from the sample based on data quality protocols, leaving an analytic sample of 1403 participants. Randomization resulted in 469 individuals in CBT-kernels arm, 466 in the Inoculation arm, and 468 in the Standard public health messaging arm (Figure 1).

Following our theoretical premise that our intervention will impact the uptake of COVID-19 vaccination, the investigators define our primary outcome as self-reported receipt of a COVID vaccine dose in the 4 weeks post-intervention. Risk ratios will be used to estimate and compare the proportion of participants in each arm who achieved the outcome. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances and conduct a mediation analysis to better understand the intervention's mechanisms of action.

Outcome measures

Outcome measures
Measure
Attitudinal Inoculation Intervention
n=466 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation. Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Cognitive Behavioral Therapy-informed Intervention
n=469 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging. Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Conventional Public Health Messaging
n=468 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging. Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Self-reported Receipt of COVID Vaccine Dose by 4 Weeks Post-intervention
Received vaccine
4 Participants
7 Participants
6 Participants
Self-reported Receipt of COVID Vaccine Dose by 4 Weeks Post-intervention
Did not receive vaccine
462 Participants
462 Participants
462 Participants

SECONDARY outcome

Timeframe: 4 weeks post-intervention

Population: Of the 1,403 participants analyzed at baseline, 59 participants were lost to follow up (20 in CBT arm, 21 in inoculation arm, and 18 in standard arm)

The investigators will estimate vaccine hesitancy at baseline, immediately post-intervention, 4 weeks post-intervention, and at 6 months post-intervention. People who indicate that they are "not willing" to get a vaccine dose will be defined as vaccine resistant, people who indicate that they are "somewhat willing" will be described as vaccine hesitant, and people who report that they are "very willing" or who report having received a vaccine dose will be classified as vaccine willing. Risk ratios will be used to estimate and compare the proportion of participants in each arm who are either vaccine resistant or vaccine hesitant to those who are vaccine willing at each time point. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances.

Outcome measures

Outcome measures
Measure
Attitudinal Inoculation Intervention
n=445 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation. Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Cognitive Behavioral Therapy-informed Intervention
n=449 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging. Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Conventional Public Health Messaging
n=450 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging. Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Participants Classified as Vaccine Willing
168 Participants
138 Participants
139 Participants

SECONDARY outcome

Timeframe: 6 months post-intervention

Population: Of the 1,403 participants analyzed, 74 were lost to follow up by month 6 (25 in CBT arm, 23 in inoculation arm, and 26 in standard arm)

The investigators define our outcome as self-reported receipt of a COVID vaccine dose in the 6 months post-intervention. Risk ratios will be used to estimate and compare the proportion of participants in each arm who achieved the outcome. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances and conduct a mediation analysis to attempt to better understand the intervention's mechanisms of action.

Outcome measures

Outcome measures
Measure
Attitudinal Inoculation Intervention
n=443 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation. Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Cognitive Behavioral Therapy-informed Intervention
n=444 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging. Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Conventional Public Health Messaging
n=411 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging. Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Self-reported Receipt of a COVID Vaccine Dose by 6 Months Post-intervention
72 Participants
61 Participants
57 Participants

SECONDARY outcome

Timeframe: 6-months post-intervention

Population: Of the 1,403 participants analyzed at baseline, 76 participants were lost to follow up by month 6 (26 in CBT arm, 23 in inoculation arm, and 27 in standard arm)

The investigators will estimate vaccine hesitancy at baseline, immediately post-intervention, 4 weeks post-intervention, and at 6 months post-intervention. People who indicate that they are "not willing" to get a vaccine dose will be defined as vaccine resistant, people who indicate that they are "somewhat willing" will be described as vaccine hesitant, and people who report that they are "very willing" or who report having received a vaccine dose will be classified as vaccine willing. Risk ratios will be used to estimate and compare the proportion of participants in each arm who are either vaccine resistant or vaccine hesitant to those who are vaccine willing at each time point. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances.

Outcome measures

Outcome measures
Measure
Attitudinal Inoculation Intervention
n=443 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation. Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Cognitive Behavioral Therapy-informed Intervention
n=443 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging. Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Conventional Public Health Messaging
n=441 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging. Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Vaccine Willingness Post-intervention
202 Participants
172 Participants
152 Participants

SECONDARY outcome

Timeframe: immediately post-intervention

The investigators will estimate vaccine hesitancy at baseline, immediately post-intervention, 4 weeks post-intervention, and at 6 months post-intervention. People who indicate that they are "not willing" to get a vaccine dose will be defined as vaccine resistant, people who indicate that they are "somewhat willing" will be described as vaccine hesitant, and people who report that they are "very willing" or who report having received a vaccine dose will be classified as vaccine willing. Risk ratios will be used to estimate and compare the proportion of participants in each arm who are either vaccine resistant or vaccine hesitant to those who are vaccine willing at each time point. The investigators will adjust for differences in measured pre-baseline variables to address potential imbalances.

Outcome measures

Outcome measures
Measure
Attitudinal Inoculation Intervention
n=466 Participants
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation. Attitudinal inoculation: A brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Cognitive Behavioral Therapy-informed Intervention
n=469 Participants
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging. Cognitive-behavioral therapy-informed intervention: A brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Conventional Public Health Messaging
n=468 Participants
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging. Conventional public health messaging: A brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Vaccine Willingness Post-intervention
153 Participants
133 Participants
141 Participants

Adverse Events

Attitudinal Inoculation Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Cognitive Behavioral Therapy-informed Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Conventional Public Health Messaging

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Denis Nash

CityUNYSPH

Phone: 3473316554

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place